Ketamine safety and tolerability in clinical trials for treatment-resistant depression September 2, 2014
(R,S)-Ketamine metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine increase the mammalian target of rapamycin function July 1, 2014
Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling April 30, 2014
Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers April 26, 2014
Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles March 17, 2014
